PE Tech Report


Like this article?

Sign up to our free newsletter

1315 Capital completes single close on over USD300m healthcare growth equity fund

Private equity firm 1315 Capital has held the single close of 1315 Capital II, a healthcare growth equity fund, at its hard cap over USD300 million, exceeding its USD250 million target.

Similar to the first fund, 1315 Capital II includes endowment, foundation, public and private pension, and family office limited partners.
“We appreciate the ongoing partnership with our management teams and investors as we continue to support innovation and solutions across healthcare,” says Adele Oliva, Founding Partner. 1315 Capital will invest on average USD10-USD30 million into existing companies, or as part of the creation of a commercial stage ‘jumpstart’. Of the eight current 1315 Capital portfolio companies, four have been ‘jumpstarts’ where 1315 Capital partnered with experienced management teams on acquiring or licensing commercial stage assets as a platform for growth.
Since closing its first fund in 2016, the 1315 Capital team has expanded, adding senior investment professionals Matthew Reber and Edward Chan to the firm. In addition, 1315 Capital Operating Partners Tim Einwechter, Rick Ferreira, Antony Koblish, John Spitznagel, Greg Stokes, and Paul Touhey will continue to work alongside the investment team and portfolio companies.
“Our Operating Team model remains a unique and powerful part of our strategy,” says Michael Koby, Founding Partner. “The teams help to identify compelling potential portfolio investments, as well as add to the success and growth of these companies.”
The new fund brings 1315 Capital’s total assets under management to more than USD500 million.

Like this article? Sign up to our free newsletter